Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department

The University of Texas Health Science Center, Houston

Summary

The purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DPP® HIV-Syphilis rapid POC test into an ongoing Emergency Department (ED) testing program and to determine whether dual rapid testing improves early initiation of HIV therapy in pregnant patients with newly identified HIV infection.

Eligibility

Age range: 14–45 years
Sex: Female
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: * Pregnancy * Presentation to the ED or obstetrical triage during the index pregnancy. * No established prenatal care (≤1 visit) and/or no documented HIV or syphilis testing during the current pregnancy. Exclusion Criteria: * Medically unstable or critically ill at the time of ED presentation. * Incarcerated at the time of ED presentation. * Decline participation in testing (opt-out) or refuse survey participation.

Interventions

Diagnostic Test
Chembio HIV/Syphilis rapid Point of Care (POC) test
Participants will undergo dual rapid HIV/syphilis testing by fingerstick using the Chembio DPP® HIV-Syphilis System.
Diagnostic Test
Laboratory-based HIV and syphilis testing
Laboratory-based HIV and syphilis testing

Location

The University of Texas Health Science Center at Houston
Houston, Texas
Irene.Stafford@uth.tmc.edu (713) 500-6412

Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department

Summary

Eligibility

Interventions

Location

Run this study?

Details

Conditions